Literature DB >> 25560189

Genotype frequencies of VKORC1 and CYP2C9 in native and Mestizo populations from Mexico, potential impact for coumarin dosing.

Beatriz Villegas-Torres1, Francisco Sánchez-Girón2, Karla Jaramillo-Villafuerte3, Xavier Soberón4, Vanessa Gonzalez-Covarrubias5.   

Abstract

The collection of pharmacogenetic variants in Mexican populations remains incomplete, thus, we aimed to characterize the genotype frequency of 11 SNP on CYP2C9 and VKORC1 in more than one-thousand individuals, and to explore their potential impact on coumarin dosing. In natives, genotype frequencies indicate that over 92% would reflect an extensive metabolism. For Mestizo populations, the proportion of CYP2C9 extensive (79%), intermediate (20.0%) and poor metabolizers (1.0%) was significantly different from that of natives, and varied among the different states of Mexico. Genotype frequencies of 7 SNP on VKORC1, were more homogenously distributed among natives and Mestizos. VKORC1 haplotype analysis revealed that most natives can be grouped into haplotypes H1 or H7-H8, while Mestizos showed a wider frequency distribution for other haplotypes. Our observations confirm previous reports on the genotype distribution of major CYP2C9 alleles, and contribute to the collection of genotype frequencies on relevant VKORC1 variants.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CYP2C9; Mexican populations; VKORC1

Mesh:

Substances:

Year:  2015        PMID: 25560189     DOI: 10.1016/j.gene.2014.12.068

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations.

Authors:  Vanessa Gonzalez-Covarrubias; José Jaime Martínez-Magaña; Regina Coronado-Sosa; Beatriz Villegas-Torres; Alma D Genis-Mendoza; Pablo Canales-Herrerias; Humberto Nicolini; Xavier Soberón
Journal:  Pharm Res       Date:  2016-07-07       Impact factor: 4.200

2.  The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy.

Authors:  Meisam Saberi; Zahra Ramazani; Homeira Rashidi; Alihossein Saberi
Journal:  Vasc Health Risk Manag       Date:  2020-06-18

3.  Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico.

Authors:  Vanessa Gonzalez-Covarrubias; Marlet Morales-Franco; Omar F Cruz-Correa; Angélica Martínez-Hernández; Humberto García-Ortíz; Francisco Barajas-Olmos; Alma Delia Genis-Mendoza; José Jaime Martínez-Magaña; Humberto Nicolini; Lorena Orozco; Xavier Soberón
Journal:  Front Pharmacol       Date:  2019-10-10       Impact factor: 5.810

4.  Pharmacogenetic Variation in Over 100 Genes in Patients Receiving Acenocumarol.

Authors:  Vanessa Gonzalez-Covarrubias; Javier Urena-Carrion; Beatriz Villegas-Torres; J Eduardo Cossío-Aranda; Sergio Trevethan-Cravioto; Raul Izaguirre-Avila; O Javier Fiscal-López; Xavier Soberon
Journal:  Front Pharmacol       Date:  2017-11-23       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.